Corpus Intelligence IC Memo — JACKSON COUNTY MEMORIAL HOSPITAL 2026-04-26 05:27 UTC
IC Memo — JACKSON COUNTY MEMORIAL HOSPITAL
Investment Committee Memorandum | OK | 49 beds | Grade C | EBITDA uplift $5.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

JACKSON COUNTY MEMORIAL HOSPITAL

CCN 370022 | JACKSON, OK | 49 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

JACKSON COUNTY MEMORIAL HOSPITAL is a 49-bed rural/critical access in JACKSON, OK with $75.5M in net patient revenue and a -10.7% operating margin. The hospital serves a payer mix of 51.1% Medicare, 16.9% Medicaid, and 32.0% commercial.

Thesis: Turnaround. Our ML models identify $5.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -10.7% to -3.3% (+736bps).

Net Revenue HCRIS$75.5M
Current EBITDA COMPUTED$-8.0M
Operating Margin COMPUTED-10.7%
Occupancy HCRIS35.8%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS40.5%
Distress Probability ML56.1%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
88
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -10.7% places it below the state median. Among 88 size-comparable peers (24-98 beds), the median margin is -9.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-98), prioritizing same-state peers. 88 hospitals in the comp set.

HospitalStateBedsRevenueMargin
JACKSON COUNTY MEMORIAL HOSPIT (Target)OK49$75.5M-10.7%
OKLAHOMA HEART HOSPITALOK97$342.0M-2.8%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
OKLAHOMA HEART HOSPITAL SOUTHOK43$148.5M-0.6%
OKLAHOMA SURGICAL HOSPITALOK74$146.2M17.7%
COMMUNITY HOSPITALOK45$143.9M21.7%
NORTHEASTERN HEALTH SYSTEMOK80$134.6M-9.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.6M+210bp18mo
Cost to Collect4.5%2.5%$1.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$919K+122bp9mo
Clean Claim Rate88.0%96.0%$48K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.6M
Cost to Collect
$1.5M
Denial Rate Reduction
$1.5M
A/R Days Reduction
$919K
Clean Claim Rate
$48K
Total EBITDA Uplift$5.6M
Current EBITDA$-8.0M
+ RCM Uplift+$5.6M
Pro Forma EBITDA$-2.5M
Current Margin-10.7%
Pro Forma Margin-3.3%
WC Released (1x)$2.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-12.4M$2.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-12.4M$-1.3M0.00x-100.0%
Bull Case9.0x11.0x$-11.1M$13.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-11.1M$11.0M0.00x-100.0%
Bear Case11.0x10.0x$-13.6M$-21.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-13.6M$-27.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
HighElevated distress probabilityModel estimates 56.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 88 hospitals with 24-98 beds
  • Same-state prioritization (n=89)
  • Comp margins: P25=-22.7% / P50=-9.0% / P75=3.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.